NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/26/2020
Back to search
Official data from USPTO
LIPOVITAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/26/2020
Trademark type
Word
Nice classes
5
Filing date
07/30/2009
Registration date
03/16/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2020
Last transaction
03/26/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/01/2002
First use in commerce
07/01/2002
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
JOINER, KATINA JACKSON
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
TAISHO PHARMACEUTICAL CO., LTD.
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
dietary supplements; liquid vitamins
Publications
History of USPTO decisions and trademark events.
26 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/26/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/26/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/26/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
01/29/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/16/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/11/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/11/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/11/2016
E815
TEAS SECTION 8 & 15 RECEIVED
02/15/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2009
PUBO
PUBLISHED FOR OPPOSITION
12/29/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/24/2009
ALIE
ASSIGNED TO LIE
11/24/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
11/06/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/06/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
11/06/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/06/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2009
GNRT
NON-FINAL ACTION E-MAILED
11/03/2009
CNRT
NON-FINAL ACTION WRITTEN
11/03/2009
DOCK
ASSIGNED TO EXAMINER
11/03/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2009
NWAP
NEW APPLICATION ENTERED
08/03/2009
Continuous trademark protection
Get notified about every new filing that threatens LIPOVITAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.